ILMN Upgraded by UBS -- Price Target Raised to $260

gurufocus.com · 2026-09-09

Illumina (ILMN) Analyst Rating Upgrade - A Comprehensive Analysis On October 12, 2023, UBS upgraded Illumina (ILMN) to a Buy rating with a new price target o

TickrTrends take: UBS upgraded ILMN and raised its price target to 260, which represents confidence in the company's near-term prospects within the Healthcare sector. Given TickrTrends' current assessment that ILMN is overvalued, investors focused on valuation metrics should monitor whether this analyst upgrade reflects a genuine reassessment of the company's fundamentals or merely reduces the gap between market price and intrinsic value estimates. The divergence between the bullish analyst call and the overvaluation signal suggests close attention to earnings performance and margin trends will be critical for determining whether the stock's valuation is justified.

Read the full story at gurufocus.com →